Sign in

CIK 0001178670

  • Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770602661
Phone
+1 617-551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-20 MARAGANORE JOHN Chief Executive Officer Sale −5,013 $144.33 $724K 197,589
2020-05-20 MARAGANORE JOHN Chief Executive Officer Exercise or conversion · Stock Option (right to buy) −34,765 69,530
2020-05-06 Greenstreet Yvonne Chief Operating Officer Exercise or conversion +50,000 $77.10 $3.9M 54,820
2020-05-06 Greenstreet Yvonne Chief Operating Officer Sale −50,000 $150.00 $7.5M 4,820
2020-05-06 Greenstreet Yvonne Chief Operating Officer Exercise or conversion · Stock Option (right to buy) −50,000 75,000
2020-05-05 Greenstreet Yvonne Chief Operating Officer Exercise or conversion +6,250 $42.22 $264K 11,070
2020-05-05 Greenstreet Yvonne Chief Operating Officer Exercise or conversion +1,561 $42.22 $66K 12,631
2020-05-05 Greenstreet Yvonne Chief Operating Officer Sale −7,811 $140.00 $1.1M 4,820
2020-05-05 Greenstreet Yvonne Chief Operating Officer Exercise or conversion · Performance Stock Option 2016 (right to buy) −6,250 650
2020-05-05 Greenstreet Yvonne Chief Operating Officer Exercise or conversion · Stock Option (right to buy) −1,561 14,064
2020-04-20 KEATING LAURIE EVP, Chief Legal Officer Exercise or conversion +10,000 $77.40 $774K 24,492
2020-04-20 KEATING LAURIE EVP, Chief Legal Officer Sale −10,000 $139.00 $1.4M 14,492
2020-04-20 KEATING LAURIE EVP, Chief Legal Officer Exercise or conversion · Stock Option (right to buy) −10,000 42,000
2020-04-20 Vaishnaw Akshay President, R&D Exercise or conversion +21,000 $42.22 $887K 35,119
2020-04-20 Vaishnaw Akshay President, R&D Exercise or conversion +971 $42.22 $41K 36,090
2020-04-20 Vaishnaw Akshay President, R&D Sale −21,971 $140.00 $3.1M 14,119
2020-04-20 Vaishnaw Akshay President, R&D Exercise or conversion · Performance Stock Option 2016 (right to buy) −21,000 0
2020-04-20 Vaishnaw Akshay President, R&D Exercise or conversion · Stock Option (right to buy) −971 5,279
2020-04-07 Greene Barry E President Grant or award +5,417 63,899
2020-04-07 Greene Barry E President Shares withheld for taxes −1,599 $104.75 $167K 62,300

Page 77 of 80 · 1,590 trades